Actively Recruiting

Phase 4
Age: 18Years - 65Years
All Genders
ID06423235

Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules: a Multicenter, Prospective, Randomized, Double-blind, Placebo-controlled Study

Led by Xintian Pharmaceutical · Updated on 2026-03-24

234

Participants Needed

22

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the efficacy and safety of Prunella oral liquid in adults with benign thyroid nodules. This phase 4, multicenter, randomized, double-blind, placebo-controlled trial aims to provide post-marketing reevaluation data on this treatment. Eligible participants have thyroid nodules confirmed benign by biopsy and normal thyroid hormone and antibody levels. The study includes 234 subjects recruited across multiple centers in China and focuses on changes in nodule volume and related health measures over time. Participants are randomly assigned to one of four groups receiving either a regular or double dose of Prunella oral liquid or a matching placebo at the same doses. Treatment lasts for 9 months, with follow-up visits scheduled at 3, 6, 9, and 12 months. Dosing is oral, twice daily, and the study includes monitoring for treatment effects and safety measures. During the study, participants undergo thyroid ultrasound examinations and blood tests to assess nodule size, thyroid function, antibody levels, and quality of life through questionnaires. Researchers track changes in nodule volume and diameter as primary and secondary outcomes, along with safety assessments such as adverse event monitoring and laboratory tests. The total participation duration spans up to 12 months, with thorough evaluations at specified intervals to understand treatment impact and safety.

CONDITIONS

Brief Title

Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 65 years old
  • Thyroid ultrasound shows single or dominant solid nodules between 1 cm and less than 3 cm
  • Nodules classified as C-TIRADS 3 to 4A
  • Benign nodules confirmed by fine needle aspiration biopsy (Bethesda Class II)
  • Normal serum TSH, free thyroid hormones (FT3, FT4), and normal thyroid antibody levels (TgAb, TPOAb)
  • Meet traditional Chinese medicine diagnostic criteria for thyroid nodules
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Diagnosis of Yang deficiency syndrome with symptoms like shortness of breath, abdominal pain, diarrhea, chills, exhaustion, pale tongue, and weak pulse
  • Pregnant, lactating, or planning pregnancy within the next 12 months
  • Signs of suspected thyroid cancer or confirmed malignancy by biopsy
  • Indications for thyroid nodule surgery such as significant local symptoms or tumor location
  • Use of prunella or similar Chinese medicines within the past month
  • Use of glucocorticoids within the last 3 months
  • Planned or previous thyroid hormone, iodine, antithyroid drug, ablation, neck radiation, or surgery treatments during the study period
  • History of parathyroid tumor, medullary thyroid cancer, other malignancies, serious cardiovascular, liver, kidney disease, osteoporosis, or mental illness
  • Family history of thyroid cancer or thyroid cancer syndrome
  • Elevated liver enzymes or blood creatinine beyond specified limits
  • Known allergy to the investigational drug or its ingredients
  • Other conditions deemed unsuitable by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 12 months

Participants take Prunella oral liquid or placebo twice daily to treat thyroid nodules.

Visits at approximately 3, 6, 9, and 12 months during treatment

Trial Site Locations

Total: 22 locations

1

Second Hospital of Army Military Medical University

Chongqing, Chongqing Municipality, China

Actively Recruiting

2

Xiamen Hospital of Traditional Chinese Medicine

Xiamen, Fujian, China

Actively Recruiting

3

People's Hospital of Guangdong Province

Guangzhou, Guangdong, China

Actively Recruiting

4

Shenzhen Hospital of Peking University

Shenzhen, Guangdong, China

Actively Recruiting

5

Shunde Hospital of Southern Medical University

Shunde, Guangdong, China

Actively Recruiting

6

Wuhan First Hospital

Wuhan, Hubei, China

Actively Recruiting

7

Jiangsu Province Hospital of Integrated Chinese and Western Medicine

Nanjing, Jiangsu, China

Actively Recruiting

8

Xuzhou Medical University Hospital

Xuzhou, Jiangsu, China

Actively Recruiting

9

The Second Hospital of Dalian Medical University

Dalian, Liaoning, China

Actively Recruiting

10

The First Hospital of China Medical University

Shenyang, Liaoning, China, 200032

Actively Recruiting

11

Hospital of Liaoning University of Chinese Medicine

Shenyang, Liaoning, China

Actively Recruiting

12

People's Hospital of Liaoning Province

Shenyang, Liaoning, China

Actively Recruiting

13

The First Hospital of Qingdao University

Qingdao, Shandong, China

Actively Recruiting

14

Weifang People's Hospital

Weifang, Shandong, China

Actively Recruiting

15

Weihai Hospital

Weihai, Shandong, China

Actively Recruiting

16

Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

Actively Recruiting

17

Shanghai 10th People's Hospital

Shanghai, Shanghai Municipality, China

Actively Recruiting

18

Shanghai First People's Hospital

Shanghai, Shanghai Municipality, China

Actively Recruiting

19

Shanghai Pudong Zhoupu Hospital

Shanghai, Shanghai Municipality, China

Actively Recruiting

20

First People's Hospital of Yunnan Province

Kunming, Yunnan, China

Actively Recruiting

21

The First Hospital of Kunming Medical University

Kunming, Yunnan, China

Actively Recruiting

22

Zhejiang Province Hospital of Integrated Chinese and Western Medicine

Hangzhou, Zhejiang, China

Actively Recruiting

Loading map...

Research Team

W

Wenjing Ji

B

Biao Chen

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Similar Trials

Development and Evaluation of Ultrasound Imaging Acquisition...

Pancreatic Cancer

Actively Recruiting

7 locations

Active Surveillance for Small Thyroid Nodules With Bethesda ...

Thyroid Cancer

Actively Recruiting

1 location

Contrast-enhanced Ultrasound Improves the Diagnostic Perform...

Thyroid Nodule

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here